Gupta et al., " ペンフィガスにおける超低用量リトゥキシマブ: 臨床的有効性または免疫学的過量投与"への反応
Shan Cao1, Tingting Liu1, Wenchao Li1
1Dermatology Hospital of Shandong First Medical University, Jinan, Shandong province, China; .Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong province, China.
Journal of the American Academy of Dermatology
|August 31, 2025
まとめ
No abstract available in PubMed .
関連する概念動画
Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...


